12 / 154
338
11. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms
of the central nervoussystem in survivors of childhood cancer:
a report from the Childhood Cancer Survivor Study. J Natl
Cancer Inst 2006;98(21):1528–37.
12. Little MP, de Vathaire F, Shamsaldin A, et al. Risks of brain
tumour following treatment for cancer in childhood:
modification by genetic factors, radiotherapy and
chemotherapy. Int J Cancer 1998;78(3):269–75.
13. Walter AW, Hancock ML, Pui CH, et al. Secondary brain
tumors in children treated for acute lymphoblastic leukemia
at St Jude Children’s Research Hospital. J Clin Oncol
1998;16(12):3761–7.
14. Braganza MZ, Kitahara CM, Berrington de Gonza´lez A,
et al. Ionizing radiation and the risk of brain and central
nervous system tumors: a systematic review. Neuro Oncol
2012;14(11):1316–24.
15. Hottinger AF, Khakoo Y. Neurooncology of familial cancer
syndromes. J Child Neurol 2009;24(12):1526–35.
16. Brenner AV, Linet MS, Fine HA, et al. History of allergies and
autoimmune diseases and risk of brain tumors in adults. Int J
Cancer 2002;99(2):252–9.
17. Wiemels JL, Wiencke JK, Sison JD, et al. History of allergies
among adults with glioma and controls. Int J Cancer
2002;98(4):609–15.
18. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, et al. History
of allergies and risk of glioma in adults. Int J Cancer
2006;119(9):2165–72.
19. Schwartzbaum J, Jonsson F, Ahlbom A, et al. Cohort studies
of association between self-reported allergic conditions,
immune-related diagnoses and glioma and meningioma risk.
Int J Cancer 2003;106(3):423–8.
20. Schlehofer B, Blettner M, Preston-Martin S, et al. Role of
medical history in brain tumour development. Results from
the international adult brain tumour study. Int J Cancer
1999;82(2):155–60.
21. Walker AE, Robins M, Weinfeld FD: Epidemiology of brain
tumors: the national survey of intracranial neoplasms.
Neurology. 35:219-226 1985
22. Guomundsson KR: A survey of tumors of the central nervous
system in Iceland during the 10-year period 1954-1963.
Acta Neurol Scand. 46:538-552 1970
23. Percy AK, Elveback LR, Okazaki H, et al.: Neoplasms of the
central nervous system. Epidemiologic considerations.
Neurology. 22:40-48 1972
24. Fogelholm R, Uutela T, Murros K: Epidemiology of central
nervous system neoplasms: a regional survey in central
Finland. Acta Neurol Scand. 69:129-136 1984
25. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA Cancer
J Clin. 45:8-30 1995
26. Posner JB, Chernik NL: Intracranial metastases from systemic
cancer. Adv Neurol.19:579-592 1978
27. Takakura K, Sano K, Hojo S, et al.: Metastatic Tumors of the
Central Nervous System.1982 Igaku-Shoin New York
28. Cairncross JG, Posner JB: Themanagement of brainmetastases.
Walker MD Oncology of the Nervous System. 1983 Martinus
Nijhof Boston 341-377
29. Youmans JR. Neurological Surgery, A Comprehensive Reference
Guide to the Diagnosis and Management of Neurosurgical
Problems. Saunders; 1973. Vol 2 pag 1410
30. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases.
Curr Oncol Rep. 2012;14(1):48-54.
31. Tsao MN, Rades D, Wirth A, et al. Radiotherapeutic and surgical
management for newly diagnosed brain metastasis(es): An
American Society for Radiation Oncology evidence-based
guideline. Pract Radiat Oncol. 2012;2(3):210-25.
32. Serie de defunciones por tumores malignos según edad Chile
1997-2013.
33. Díaz T Violeta, Yáñez L Alfredo, Ponce O Carolina, Villegas
Rodrigo, Pastén Juan A. Tendencia de la mortalidad por
tumores cerebrales malignos en Chile: Análisis de tasas. Rev.
chil. neuro-psiquiatr. [Internet]. 2006 Dic [citado 2017 Mar
26] ; 44( 4 ): 263-270
[REV. MED. CLIN. CONDES - 2017; 28(3) 332-338]